Cargando…

Long-Term Oral Bisphosphonate Compliance Focusing on Switching of Prescription Pattern

BACKGROUND: Factors determining bisphosphonate compliance are not fully understood. We examined fluctuations in oral bisphosphonate dosing intervals to gauge therapeutic compliance in patients with osteoporosis. MATERIALS AND METHODS: Hospital data accruing between 2010 and 2017 were accessed to ret...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ko, Kyung Rae, Lee, Sangcheol, Oh, Seo Yoon, Kim, Ki-duk, Park, Sin Hyung, Lee, Soonchul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588837/ https://www.ncbi.nlm.nih.gov/pubmed/33122894 http://dx.doi.org/10.2147/PPA.S266697

Ejemplares similares

Effect of Dosing Interval on Compliance of Osteoporosis Patients on Bisphosphonate Therapy: Observational Study Using Nationwide Insurance Claims Data
por: Lee, Hyunil, et al.
Publicado: (2021)

Which Bisphosphonate? It's the Compliance!: Decision Analysis
por: Lee, You Jin, et al.
Publicado: (2016)

Oral bisphosphonate compliance and persistence: a matter of choice?
por: Silverman, S. L., et al.
Publicado: (2010)

Impact on Bisphosphonate Persistence and Compliance: Daily Postprandial Administration
por: Park, Chan Ho, et al.
Publicado: (2019)

Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis
por: Park, Ji-Heh, et al.
Publicado: (2017)

Can Alarming Improve Compliance with Weekly Bisphosphonate in Patients with Osteoporosis?
por: Nho, Jae-Hwi, et al.
Publicado: (2016)

Oral Bisphosphonate and Risk of Esophageal Cancer: A Nationwide Claim Study
por: Seo, Gi Hyeon, et al.
Publicado: (2015)

Criteria for the prescription of oral bisphosphonates for the treatment of osteoporosis in a series of women referred for tooth extraction
por: Diniz-Freitas, Márcio, et al.
Publicado: (2012)

Loss of treatment benefit due to low compliance with bisphosphonate therapy
por: Penning-van Beest, F. J. A., et al.
Publicado: (2007)

Non-compliance of prescriptions by the patients
por: Shamasundar, C.
Publicado: (2008)

Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA
por: Asche, C., et al.
Publicado: (2009)

Effect of Lumbar Spinal Stenosis on Treatment of Osteoporosis: Comparison of Three Oral Bisphosphonate Therapies
por: Park, Hyung-Youl, et al.
Publicado: (2023)

Epidemiology of pediatric fractures before versus during the coronavirus disease 2019 pandemic
por: Oh, Chi Hoon, et al.
Publicado: (2022)

Recapitulation of First Pass Metabolism Using 3D Printed Microfluidic Chip and Organoid
por: Lee, Bo-Eun, et al.
Publicado: (2021)

Oral bisphosphonates and colorectal cancer
por: Vogtmann, Emily, et al.
Publicado: (2017)

Bisphosphonate-induced Severe Hypocalcemia - A Case Report -
por: Do, Won-Seok, et al.
Publicado: (2012)

Bisphosphonates Prescription for Patients With Hip Fractures Based on Evaluation by a Dentist
por: Inoue, Hayato, et al.
Publicado: (2023)

The association between compliance and persistence with bisphosphonate therapy and fracture risk: A review
por: Adachi, Jonathan, et al.
Publicado: (2007)

Compliance and patient reported toxicity from oral adjuvant bisphosphonates in patients with early breast cancer. A cross sectional study
por: Wilson, C., et al.
Publicado: (2019)

Risk Factors of New Adjacent Compression Fracture after Percutaneous Vertebroplasty: Effectiveness of Bisphosphonate in Osteoporotic or Osteopenic Elderly Patients
por: Seo, Dae-Hyun, et al.
Publicado: (2014)

Atypical Fracture of the Proximal Shaft of the Ulna Associated with Prolonged Bisphosphonate Therapy
por: Oh, Byung Hak, et al.
Publicado: (2018)

Atrial fibrillation and the use of oral bisphosphonates
por: Pazianas, Michael, et al.
Publicado: (2011)

The Effects of Selenium on Bone Health: From Element to Therapeutics
por: Yang, Taeyoung, et al.
Publicado: (2022)

Reliability of the TT-TG Index Versus TT-TG Distance on MRI: Morphometric Analyses in Asian Children and Adolescents
por: Park, Sin Hyung, et al.
Publicado: (2023)

Bisphosphonate inhibits the expression of cyclin A2 at the transcriptional level in normal human oral keratinocytes
por: Lee, Rachel S., et al.
Publicado: (2017)

Compliance and persistence with daily, weekly, and monthly bisphosphonates for osteoporosis in Japan: analysis of data from the CISA
por: Kishimoto, Hideaki, et al.
Publicado: (2015)

Administration of bisphosphonate for hypercalcemia associated with oral cancer
por: Onizawa, Kojiro, et al.
Publicado: (2006)

Eliminating the need for fasting with oral administration of bisphosphonates
por: Pazianas, Michael, et al.
Publicado: (2013)

Novel formulations of oral bisphosphonates in the treatment of osteoporosis
por: Fuggle, Nicholas, et al.
Publicado: (2022)

Bisphosphonates and Their Connection to Dental Procedures: Exploring Bisphosphonate-Related Osteonecrosis of the Jaws
por: Lee, Emily Sunny, et al.
Publicado: (2023)

Characteristics of patients with osteonecrosis of the jaw with oral versus intravenous bisphosphonate treatment
por: Lee, Seung-Hun, et al.
Publicado: (2021)

The expression of substance P and calcitonin gene-related peptide is associated with the severity of tendon degeneration in lateral epicondylitis
por: Han, Soo-Hong, et al.
Publicado: (2021)

Impact of the Training on the Compliance and Persistence of Weekly Bisphosphonate Treatment in Postmenopausal Osteoporosis: A Randomized Controlled Study
por: Tüzün, Şansın, et al.
Publicado: (2013)

Long-term oxygen therapy prescription in India: Evaluation of compliance, factors affecting compliance, indications, and survival
por: Patro, Mahismita, et al.
Publicado: (2022)

Crisis-driven cholera resurgence switches focus to oral vaccine
Publicado: (2018)

Individualized diabetes nutrition education improves compliance with diet prescription
por: Lim, Hae-mi, et al.
Publicado: (2009)

Bisphosphonate related osteonecrosis of the jaws (BRONJ) in osteoporotic males
por: Kwon, Yong-Dae, et al.
Publicado: (2016)

Increase in the Serum Parathyroid Hormone Level During a Bisphosphonate Drug Holiday
por: Song, Yoon Kyung, et al.
Publicado: (2014)

Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis
por: Cotté, F.-E., et al.
Publicado: (2009)

Oral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers
por: Vogtmann, Emily, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jj77vmspl23aq7hvaj8mmt06sf